For investigating the variation of fibrinolysis in patients with uremia and the influence of dialysis on fibrnolysis, Plg, t PA, PAI and D D were examined in 20 patients with uremia and 13 healthy controls.

• 为探讨尿毒症患者纤溶系统的变化及透析对纤溶系统的影响 ,应用发色底物法和酶标法检测 2 0例尿毒症患者透析前后及对照组的纤溶酶原 (Plg)活性、组织性纤溶酶原激活剂 (t PA)活性、纤溶酶原激活剂抑制物 (PAI)活性及D 二聚体 (D D)定量。